Status
Conditions
Treatments
About
An Expanded Access Program for UROMUNE® for patients suffering from recurrent/chronic urinary tract infections of diverse etiology. This is for individuals for whom antibiotic therapy has failed, but of consideration in all cases, taking into account antibiotic-induced adverse reactions and increasing antibiotic resistance.
Full description
UROMUNE® is a mucosal immunotherapy indicated for the prevention of urinary tract infections caused by different pathogens. It works by stimulating the immune system, thus increasing the resistance against recurrent infections. The active substances are 4 inactivated and selected bacterial strains:
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Michel van Harten, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal